Table 1. Comparison of intron lengths.
Gened | N(genes)f | Aver1g | Aver-1h | L<exp(L)i | L = exp(L)j | L>exp(L)k | valuel |
All e | 19770 | 13732 | 4861 | 39.13 | 0.02 | 60.84 | ∼0 |
Housekeeping genes (HK) | 414 | 5851 | 2136 | 36.75 | 0 | 63.25 | 3.6e–16 |
Blood (BD) | 145 | 12340 | 4121 | 31.39 | 0 | 68.61 | 4.15e–9 |
Brain (BRA) | 260 | 22986 | 7814 | 35.95 | 0 | 64.05 | 1.82e–12 |
Breast (BRE) | 54 | 15447 | 12135 | 52.08 | 0 | 47.92 | 0.9942 |
Cervix (CX) | 53 | 21039 | 5109 | 38.46 | 0 | 61.54 | 1.92e–6 |
Colon (CO) | 37 | 22325 | 5605 | 51.43 | 0 | 48.57 | 3e–3 |
Endometrium (ENDO) | 125 | 19587 | 5629 | 30.83 | 0 | 69.17 | 1.03e–11 |
Esophagus (ES) | 111 | 15358 | 4290 | 33.96 | 0 | 66.04 | 2.96e–5 |
Kidney (KI) | 550 | 17207 | 5760 | 36.55 | 0 | 63.45 | 3.9e–34 |
Liver (LI) | 570 | 14167 | 4627 | 34.39 | 0 | 65.61 | 6.17e–35 |
Lung (LU) | 610 | 15782 | 5030 | 33.56 | 0 | 66.44 | 4.91e–42 |
Muscle (MU) | 513 | 15910 | 5269 | 36.36 | 0 | 63.64 | 1.29e–31 |
Myometrium (MY) | 102 | 21346 | 5802 | 34.65 | 0 | 65.35 | 1.07e–7 |
Ovary (OV) | 228 | 16622 | 4483 | 36.87 | 0 | 63.13 | 4.73e–20 |
Placenta (PL) | 105 | 18213 | 4302 | 37.76 | 0 | 62.24 | 7.87e–8 |
Prostate (PR) | 624 | 16970 | 5504 | 35.85 | 0 | 64.15 | 8.2e–41 |
Stomach (ST) | 31 | 36466 | 7048 | 24 | 0 | 76 | 5.37e–5 |
Spleen (SP) | 24 | 13525 | 3173 | 27.27 | 0 | 72.73 | 1.21e–2 |
Testes (TE) | 25 | 32527 | 8853 | 22.73 | 0 | 77.27 | 3.49e–1 |
Vulva (VU) | 162 | 15179 | 3621 | 33.11 | 0 | 66.89 | 1.34e–11 |
d: the name of each group ;
e: all sample genes;
f: the number of genes in each group;
g: the average lengths (unit: bp) of the first introns;
h: the average lengths of the non-first introns;
i: the gene proportions observed with the first intron length shorter than their expected length;
j: the gene proportions observed with the first intron length equal to their expected length;
k: the gene proportions observed with the first intron length longer than their expected length;
l: the value of KS test.